Genmab · 1 week ago
Clinical Data Manager Intern
Genmab is an international biotechnology company dedicated to improving the lives of patients through innovative antibody therapeutics. The Clinical Data Manager Intern will support drug development efforts by gaining hands-on experience in clinical data management activities during a 10-week summer internship.
BiotechnologyHealth CareManufacturingMedical
Responsibilities
Contribute to meetings within the data management group
Shadow vendor oversight related to key deliverables e.g. eCRF design development, review of the eCRF completion guide, UAT, approve eCRF go live, Data management plan, Data validation plan, Data cleaning activities
Evaluate trends in DM raised queries, ensuring data quality
Proactively identify risks management related to data management activities in relation to trial conduct
Review and provide input to protocol and amendment development
Attend clinical trial team meetings as required
Support timely development, update and maintenance of dashboards, if applicable
Qualification
Required
Enrollment in a Bachelor or Master's program in Health Sciences, Data Science, or a related field
Basic understanding of clinical trial regulatory environment
Strong analytical and problem-solving abilities
Excellent written and verbal communication skills
Ability to work independently and as part of a collaborative team
High attention to detail and commitment to quality work
Genuine interest in clinical research and drug development
Preferred
Demonstrates initiative, a proactive attitude, and eagerness to learn in a fast-paced environment
Effectively communicates and collaborates with team members, mentors, and stakeholders
Applies academic expertise in open-source programming languages and adapts quickly to new tools and methodologies
Maintains attention to detail and quality in all deliverables while managing multiple tasks
Actively engages in the capstone project and leverages feedback to refine technical and professional skills
Company
Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Funding
Current Stage
Public CompanyTotal Funding
$11.7BKey Investors
Morgan Stanley Senior FundingGlaxoSmithKlineIndex Ventures
2025-11-18Post Ipo Debt· $6B
2025-09-29Post Ipo Debt· $5.5B
2010-07-01Post Ipo Equity· $134M
Recent News
2026-01-19
2026-01-19
Company data provided by crunchbase